Advanced Oncotherapy - Re: AVO Stream Log - just pulled this from Beaufort...

just pulled this from Beaufort Securities's note out this morning on Research Tree... "Advanced Oncotherapy has made a significant progress in the FY2015, keeping its promises and delivered its development milestones to the timeline. In February 2016, AVO announced industrialisation agreement with Thales for LIGHT system, and further strengthened its financing through securing a £24m vendor financing agreement with Metric Capital, a pan- European private capital fund manager, to fully fund the installation of the Group’s first LIGHT machine in Harley Street. This is important news for AVO as it demonstrated not only a senior institutional lender has taken a very close look at the Group and concluded that LIGHT is viable and that its expect its first installation in Harley Street to rapidly become capable of generating strong cashflow, but also that AVO is both sufficiently confident and advanced in its planning to establish a general provision of vendor financing for its prospective international customers. In order to meet its target for the first commercial sales of LIGHT in 2017, AVO’s priorities will be to ensure the components of the LIGHT machine is compliant with the associated regulatory requirements, initial installation into the UK and to pursue commercial roll-out of the technology through existing and new partners. The Group continued to strengthen its team by appointing highly experienced senior management and shuffled the role internally to build a more commercially focussed business. As has been explained in numerous research documents, Beaufort’s commercial scenario for LIGHT is that the cost, safely, operational and size advantages its brings to the world of proton therapy, will effectively render ‘first generation’ systems all but obsolete; its development will also has potential to expand the international market for such systems from some US$2.5bn annually right now, to a figure potentially ten-times as large as LIGHT becomes the obvious successor to the similarly-priced but now relatively antiquated X-ray radiation systems that have a global installed base in excess of 20,000 units. In this respect, LIGHT uniquely faces a giant and accelerating global opportunity...."